PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,888,170 | -31.4% | 860,423 | -12.9% | 0.00% | -100.0% |
| Q2 2023 | $12,947,646 | +22.3% | 987,616 | +4.3% | 0.00% | 0.0% |
| Q1 2023 | $10,587,203 | +0.1% | 946,977 | -24.5% | 0.00% | – |
| Q4 2022 | $10,577,796 | -24.7% | 1,254,780 | +48.9% | 0.00% | -100.0% |
| Q3 2022 | $14,042,000 | +16.4% | 842,851 | +2.9% | 0.00% | 0.0% |
| Q2 2022 | $12,063,000 | -39.8% | 819,484 | +1.4% | 0.00% | 0.0% |
| Q1 2022 | $20,041,000 | -13.4% | 807,790 | +11.9% | 0.00% | 0.0% |
| Q4 2021 | $23,152,000 | -10.1% | 721,935 | +0.8% | 0.00% | 0.0% |
| Q3 2021 | $25,759,000 | -1.2% | 715,919 | +21.1% | 0.00% | 0.0% |
| Q2 2021 | $26,075,000 | +68.4% | 590,994 | +74.6% | 0.00% | 0.0% |
| Q1 2021 | $15,487,000 | +26.5% | 338,581 | +90.9% | 0.00% | 0.0% |
| Q4 2020 | $12,244,000 | – | 177,405 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XIII Associates, LLC | 994,971 | $43,898,000 | 8.08% |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 93,831 | $4,140,000 | 8.00% |
| Miura Global Management | 570,000 | $25,148,000 | 4.59% |
| Iron Triangle Partners LP | 550,000 | $24,266,000 | 2.50% |
| Beck Bode, LLC | 116,442 | $5,137,000 | 1.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,800,887 | $79,455,000 | 1.41% |
| Affinity Asset Advisors, LLC | 60,000 | $2,647,000 | 0.95% |
| PURA VIDA INVESTMENTS, LLC | 595,231 | $26,262,000 | 0.82% |
| RTW INVESTMENTS, LP | 1,129,600 | $49,838,000 | 0.75% |
| ABG Innovation Capital Partners III GP Ltd | 4,521 | $199,000 | 0.67% |